{"SLR NAME":"Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials","References":[{"title1":"Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"A systematic review of COVID-19 epidemiology based on current evidence","References":[{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"},{"title3":"A%20systematic%20review%20of%20COVID-19%20epidemiology%20based%20on%20current%20evidence"}]},{"title2":"Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems","References":[{"title3":"Coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20Iran:%20actions%20and%20problems"},{"title3":"Coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20Iran:%20actions%20and%20problems"},{"title3":"Coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20Iran:%20actions%20and%20problems"},{"title3":"Coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20Iran:%20actions%20and%20problems"}]},{"title2":"WHO. WHO COVID-19 Data Explorer. https://covid19.who.int/explorer.","References":[]},{"title2":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","References":[{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Observational%20study%20of%20hydroxychloroquine%20in%20hospitalized%20patients%20with%20Covid-19"}]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","References":[{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"}]},{"title2":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","References":[{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"}]},{"title2":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","References":[{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"}]},{"title2":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","References":[]},{"title2":"Remdesivir for the treatment of COVID-19:preliminary report","References":[]},{"title2":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","References":[]},{"title2":"SD1000: high sustained viral response rate in 1361 patients with hepatitis C genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic sofosbuvir and daclatasvir: a multicenter, Phase III clinical trial","References":[]},{"title2":"Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo","References":[{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"},{"title3":"Yellow%20fever%20virus%20is%20susceptible%20to%20sofosbuvir%20both%20in%20vitro%20and%20in%20vivo"}]},{"title2":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","References":[{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"}]},{"title2":"Sofosbuvir as treatment against dengue?","References":[]},{"title2":"Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication","References":[]},{"title2":"Emerging coronaviruses: genome structure, replication, and pathogenesis","References":[{"title3":"Emerging%20coronaviruses:%20genome%20structure,%20replication,%20and%20pathogenesis"}]},{"title2":"Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase","References":[{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"}]},{"title2":"Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses","References":[{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"}]},{"title2":"Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)","References":[{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"},{"title3":"Advanced%20bioinformatics%20rapidly%20identifies%20existing%20therapeutics%20for%20patients%20with%20coronavirus%20disease-2019%20(COVID-19)"}]},{"title2":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","References":[{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Ribavirin,%20remdesivir,%20sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"}]},{"title2":"In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease","References":[]},{"title2":"Simeprevir suppresses SARS-CoV-2 replication and synergizes with remdesivir","References":[{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"},{"title3":"Simeprevir%20suppresses%20SARS-CoV-2%20replication%20and%20synergizes%20with%20remdesivir"}]},{"title2":"The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2","References":[]},{"title2":"Evaluation of 19 antiviral drugs against SARS-CoV-2 infection","References":[]},{"title2":"Minimum costs to manufacture new treatments for COVID-19","References":[{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"}]},{"title2":"Radiologic management of COVID-19: preliminary experience of the Iranian Society of Radiology COVID-19 Consultant Group (ISRCC)","References":[]},{"title2":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","References":[{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"}]}]},{"title1":"The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19","References":[{"title2":"Treating COVID-19:off-label drug use, compassionate use, and randomized clinical trials during pandemics","References":[]},{"title2":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19","References":[{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"},{"title3":"Remdesivir:%20a%20review%20of%20its%20discovery%20and%20development%20leading%20to%20emergency%20use%20authorization%20for%20treatment%20of%20COVID-19"}]},{"title2":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","References":[{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"}]},{"title2":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","References":[{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"},{"title3":"Structure%20of%20M(pro)%20from%20SARS-CoV-2%20and%20discovery%20of%20its%20inhibitors"}]},{"title2":"Sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","References":[{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"},{"title3":"Sofosbuvir,%20galidesivir,%20and%20tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20a%20molecular%20docking%20study"}]},{"title2":"Nucleotide analogues as inhibitors of SARS-CoV polymerase","References":[{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV%20polymerase"}]},{"title2":"Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase","References":[{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"},{"title3":"Nucleotide%20analogues%20as%20inhibitors%20of%20SARS-CoV-2%20polymerase"}]},{"title2":"Prediction of small molecule inhibitors targeting the novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase","References":[]},{"title2":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","References":[{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"}]},{"title2":"In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease","References":[]},{"title2":"The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2","References":[]},{"title2":"Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome","References":[{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Adverse%20events%20associated%20with%20high-dose%20ribavirin:%20evidence%20from%20the%20Toronto%20outbreak%20of%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"SD1000: high sustained viral response rate in 1361 patients with hepatitis C genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic sofosbuvir and daclatasvir: a multicenter, phase III clinical trial","References":[]},{"title2":"The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment","References":[]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19","References":[{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"}]},{"title2":"Remdesivir for the treatment of COVID-19:preliminary report","References":[]},{"title2":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","References":[{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"}]},{"title2":"Favipiravir versus arbidol for COVID-19: a randomized clinical trial","References":[{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"},{"title3":"Favipiravir%20versus%20arbidol%20for%20COVID-19:%20a%20randomized%20clinical%20trial"}]}]},{"title1":"Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial","References":[{"title2":"SD1000: high sustained viral response rate in 1361 patients with hepatitis C genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic sofosbuvir and daclatasvir: a multicenter, phase III clinical trial","References":[]},{"title2":"Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic","References":[{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"}]},{"title2":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","References":[{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"},{"title3":"Predicting%20commercially%20available%20antiviral%20drugs%20that%20may%20act%20on%20the%20novel%20coronavirus%20(SARS-CoV-2)%20through%20a%20drug-target%20interaction%20deep%20learning%20model"}]},{"title2":"The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2","References":[]},{"title2":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","References":[]},{"title2":"Rapid Review Neurological associations of COVID-19","References":[]},{"title2":"Sofosbuvir protects human brain organoids against SARS-CoV-2","References":[]},{"title2":"The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19","References":[]},{"title2":"Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial","References":[{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"}]},{"title2":"Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single centre, randomized controlled trial","References":[{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single%20centre,%20randomized%20controlled%20trial"}]},{"title2":"Minimum costs to manufacture new treatments for COVID-19","References":[{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"},{"title3":"Minimum%20costs%20to%20manufacture%20new%20treatments%20for%20COVID-19"}]},{"title2":"Radiologic management of COVID-19: preliminary experience of the Iranian Society of Radiology COVID-19 Consultant Group (ISRCC)","References":[]},{"title2":"Favipiravir, an antiviral for COVID-19?","References":[]},{"title2":"Experimental treatment with favipiravir for COVID-19: an open-label control study","References":[{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"}]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19","References":[{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20COVID-19"}]},{"title2":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","References":[{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"}]},{"title2":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19","References":[]},{"title2":"Remdesivir for the treatment of Covid-19:preliminary report","References":[]},{"title2":"Effect of Dexamethasone in Hospitalized Patients with COVID-19: preliminary Report","References":[]},{"title2":"The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment","References":[]},{"title2":"The efficacy of 12 weeks of sofosbuvir, daclatasvir, and ribavirin in treating hepatitis C patients with cirrhosis, genotypes 1 and 3","References":[]}]},{"title1":"Efficacy and safety of sofosbuvir/ledipasvir in treatment of patients with COVID-19; A randomized clinical trial","References":[{"title2":"A Novel Coronavirus from Patients with Pneumonia in China","References":[{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","References":[{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"},{"title3":"A%20rapid%20advice%20guideline%20for%20the%20diagnosis%20and%20treatment%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20infected%20pneumonia%20(standard%20version)"}]},{"title2":"COVID-19 infection: the perspectives on immune responses","References":[{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"},{"title3":"COVID-19%20infection:%20the%20perspectives%20on%20immune%20responses"}]},{"title2":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","References":[{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"},{"title3":"Epidemiology,%20genetic%20recombination,%20and%20pathogenesis%20of%20coronaviruses"}]},{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses","References":[{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"},{"title3":"From%20SARS%20to%20MERS:%2010%20years%20of%20research%20on%20highly%20pathogenic%20human%20coronaviruses"}]},{"title2":"Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates","References":[{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"},{"title3":"Prediction%20of%20the%20SARS-CoV-2%20(2019-nCoV)%203C-like%20protease%20(3CL%20pro)%20structure:%20virtual%20screening%20reveals%20velpatasvir,%20ledipasvir,%20and%20other%20drug%20repurposing%20candidates"}]},{"title2":"Sofosbuvir (Sovaldi): The First-in-Class HCV NS5B Nucleotide Polymerase Inhibitor","References":[]},{"title2":"PK/PD and antiviral activity of anti-HCV therapy: is there still a role in the choice of treatment?","References":[]},{"title2":"Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses","References":[{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"}]},{"title2":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","References":[{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"}]},{"title2":"Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study","References":[{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"},{"title3":"Ribavirin,%20Remdesivir,%20Sofosbuvir,%20Galidesivir,%20and%20Tenofovir%20against%20SARS-CoV-2%20RNA%20dependent%20RNA%20polymerase%20(RdRp):%20A%20molecular%20docking%20study"}]},{"title2":"Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial","References":[{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"}]},{"title2":"Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a singlecentre, randomized controlled trial","References":[{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20singlecentre,%20randomized%20controlled%20trial"}]},{"title2":"The impact of sofosbuvir/ daclatasvir or ribavirin in patients with severe COVID-19","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","References":[{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"},{"title3":"The%20epidemiology%20and%20pathogenesis%20of%20coronavirus%20disease%20(COVID-19)%20outbreak"}]},{"title2":"Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis","References":[]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","References":[{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"}]},{"title2":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","References":[{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20mainly%20mild%20to%20moderate%20coronavirus%20disease%202019:%20open%20label,%20randomised%20controlled%20trial"}]},{"title2":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","References":[{"title3":"Hydroxychloroquine%20and%20azithromycin%20as%20a%20treatment%20of%20COVID-19:%20results%20of%20an%20open-label%20non-randomized%20clinical%20trial"},{"title3":"Hydroxychloroquine%20and%20azithromycin%20as%20a%20treatment%20of%20COVID-19:%20results%20of%20an%20open-label%20non-randomized%20clinical%20trial"},{"title3":"Hydroxychloroquine%20and%20azithromycin%20as%20a%20treatment%20of%20COVID-19:%20results%20of%20an%20open-label%20non-randomized%20clinical%20trial"},{"title3":"Hydroxychloroquine%20and%20azithromycin%20as%20a%20treatment%20of%20COVID-19:%20results%20of%20an%20open-label%20non-randomized%20clinical%20trial"},{"title3":"Hydroxychloroquine%20and%20azithromycin%20as%20a%20treatment%20of%20COVID-19:%20results%20of%20an%20open-label%20non-randomized%20clinical%20trial"}]},{"title2":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis","References":[]},{"title2":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state","References":[{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"},{"title3":"Association%20of%20treatment%20with%20hydroxychloroquine%20or%20azithromycin%20with%20in-hospital%20mortality%20in%20patients%20with%20COVID-19%20in%20New%20York%20state"}]},{"title2":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","References":[{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"},{"title3":"Remdesivir%20in%20adults%20with%20severe%20COVID-19:%20a%20randomised,%20double-blind,%20placebo-controlled,%20multicentre%20trial"}]},{"title2":"Remdesivir for the Treatment of Covid-19:Preliminary Report","References":[]},{"title2":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19","References":[]},{"title2":"Experimental treatment with favipiravir for COVID-19: an open-label control study","References":[{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"},{"title3":"Experimental%20treatment%20with%20favipiravir%20for%20COVID-19:%20an%20open-label%20control%20study"}]},{"title2":"Interferon-a2b treatment for COVID-19","References":[]},{"title2":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","References":[{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"},{"title3":"Triple%20combination%20of%20interferon%20beta-1b,%20lopinavir-ritonavir,%20and%20ribavirin%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20COVID-19:%20an%20open-label,%20randomised,%20phase%202%20trial"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Treating influenza with statins and other immunomodulatory agents","References":[]},{"title2":"A practical treatment for patients with Ebola virus disease","References":[]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"}]},{"title2":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications","References":[]},{"title2":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection","References":[{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"Hiding%20in%20plain%20sight:%20an%20approach%20to%20treating%20patients%20with%20severe%20COVID-19%20infection"}]},{"title2":"Potential effects of coronaviruses on the cardiovascular system: a review","References":[]},{"title2":"A new clinical trial to test high-dose vitamin C in patients with COVID-19","References":[{"title3":"A%20new%20clinical%20trial%20to%20test%20high-dose%20vitamin%20C%20in%20patients%20with%20COVID-19"},{"title3":"A%20new%20clinical%20trial%20to%20test%20high-dose%20vitamin%20C%20in%20patients%20with%20COVID-19"},{"title3":"A%20new%20clinical%20trial%20to%20test%20high-dose%20vitamin%20C%20in%20patients%20with%20COVID-19"},{"title3":"A%20new%20clinical%20trial%20to%20test%20high-dose%20vitamin%20C%20in%20patients%20with%20COVID-19"},{"title3":"A%20new%20clinical%20trial%20to%20test%20high-dose%20vitamin%20C%20in%20patients%20with%20COVID-19"}]},{"title2":"Drug targets for corona virus: A systematic review. Indian journal of pharmacology","References":[]},{"title2":"Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy","References":[{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"},{"title3":"Hepatitis%20C%20virus:%20life%20cycle%20in%20cells,%20infection%20and%20host%20response,%20and%20analysis%20of%20molecular%20markers%20influencing%20the%20outcome%20of%20infection%20and%20response%20to%20therapy"}]},{"title2":"Zika virus structure, maturation, and receptors","References":[]},{"title2":"Coronaviruses: An Overview of Their Replication and Pathogenesis","References":[{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"},{"title3":"Coronaviruses:%20An%20Overview%20of%20Their%20Replication%20and%20Pathogenesis"}]},{"title2":"Sofosbuvir and ribavirin liver pharmacokinetics in patients infected with hepatitis C virus","References":[]},{"title2":"Nucleoside/nucleotide analogue polymerase inhibitors in development","References":[]},{"title2":"Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus","References":[]},{"title2":"Antiviral nucleotide incorporation by recombinant human mitochondrial RNA polymerase is predictive of increased in vivo mitochondrial toxicity risk","References":[]},{"title2":"Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin","References":[]},{"title2":"Antiviral candidates for treating hepatitis E virus infection","References":[]},{"title2":"Distinct antiviral potency of sofosbuvir against hepatitis C and E viruses","References":[]},{"title2":"Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system","References":[]},{"title2":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","References":[{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"},{"title3":"The%20FDA-approved%20drug%20sofosbuvir%20inhibits%20Zika%20virus%20infection"}]},{"title2":"Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication","References":[]},{"title2":"The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication","References":[]},{"title2":"Cell-line dependent antiviral activity of sofosbuvir against Zika virus","References":[]},{"title2":"Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro","References":[]}]},{"title1":"Efficacy and safety of sofosbuvir/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial","References":[{"title2":"Treatment options for COVID-19: the reality and challenges","References":[{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"},{"title3":"Treatment%20options%20for%20COVID-19:%20the%20reality%20and%20challenges"}]},{"title2":"The current understanding and potential therapeutic options to combat COVID-19","References":[{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"},{"title3":"The%20current%20understanding%20and%20potential%20therapeutic%20options%20to%20combat%20COVID-19"}]},{"title2":"Role of drug repurposing in current treatment strategies against COVID-19; systemic review","References":[]},{"title2":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","References":[]},{"title2":"Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses","References":[{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"},{"title3":"Quantitative%20structure-activity%20relationship%20and%20molecular%20docking%20revealed%20a%20potency%20of%20anti-hepatitis%20C%20virus%20drugs%20against%20human%20corona%20viruses"}]},{"title2":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","References":[{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"},{"title3":"Anti-HCV,%20nucleotide%20inhibitors,%20repurposing%20against%20COVID-19"}]},{"title2":"Anti-HIV and Anti-HCV drugs are the putative inhibitors of RNA-dependent-RNA polymerase activity of NSP12 of the SARS CoV-2 (COVID-19)","References":[]},{"title2":"Structural elucidation of SARS-CoV-2 vital proteins: computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase","References":[{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"},{"title3":"Structural%20elucidation%20of%20SARS-CoV-2%20vital%20proteins:%20computational%20methods%20reveal%20potential%20drug%20candidates%20against%20main%20protease,%20Nsp12%20polymerase%20and%20Nsp13%20helicase"}]},{"title2":"Highlights on evidence-based treatment strategies for COVID-19: a review","References":[]},{"title2":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","References":[{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"},{"title3":"Structure%20of%20the%20RNA-dependent%20RNA%20polymerase%20from%20COVID-19%20virus"}]},{"title2":"Editorial - sofosbuvir/velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents","References":[]},{"title2":"Sofosbuvir as repurposed antiviral drug against COVID-19: why were we convinced to evaluate the drug in a registered/approved clinical trial?","References":[{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"},{"title3":"Sofosbuvir%20as%20repurposed%20antiviral%20drug%20against%20COVID-19:%20why%20were%20we%20convinced%20to%20evaluate%20the%20drug%20in%20a%20registered/approved%20clinical%20trial?"}]},{"title2":"In silico studies on therapeutic agents for COVID-19: drug repurposing approach","References":[{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"},{"title3":"In%20silico%20studies%20on%20therapeutic%20agents%20for%20COVID-19:%20drug%20repurposing%20approach"}]},{"title2":"Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic","References":[{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"},{"title3":"Sofosbuvir%20as%20a%20potential%20alternative%20to%20treat%20the%20SARS-CoV-2%20epidemic"}]},{"title2":"Sofosbuvir and ribavirin liver pharmacokinetics in patients infected with hepatitis C virus","References":[]},{"title2":"Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre randomized controlled trial","References":[{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"},{"title3":"Evaluation%20of%20the%20efficacy%20of%20sofosbuvir%20plus%20daclatasvir%20in%20combination%20with%20ribavirin%20for%20hospitalized%20COVID-19%20patients%20with%20moderate%20disease%20compared%20with%20standard%20care:%20a%20single-centre%20randomized%20controlled%20trial"}]},{"title2":"The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19","References":[]},{"title2":"Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial","References":[{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"},{"title3":"Sofosbuvir%20and%20daclatasvir%20compared%20with%20standard%20of%20care%20in%20the%20treatment%20of%20patients%20admitted%20to%20hospital%20with%20moderate%20or%20severe%20coronavirus%20infection%20(COVID-19):%20a%20randomized%20controlled%20trial"}]},{"title2":"Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis","References":[]},{"title2":"Gender differences in patients with COVID-19: focus on severity and mortality","References":[{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"}]},{"title2":"COVID-19: the gendered impacts of the outbreak","References":[{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"},{"title3":"COVID-19:%20the%20gendered%20impacts%20of%20the%20outbreak"}]},{"title2":"Sex and gender differences in the outcome of patients with COVID-19","References":[{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"},{"title3":"Sex%20and%20gender%20differences%20in%20the%20outcome%20of%20patients%20with%20COVID-19"}]},{"title2":"Sofosbuvir with velpatasvir","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study","References":[{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Factors%20associated%20with%20duration%20of%20viral%20shedding%20in%20adults%20with%20COVID-19%20outside%20of%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2","References":[]},{"title2":"Pharmacokinetic, pharmacodynamic, and drug-interaction profile of the hepatitis C virus NS5B polymerase inhibitor sofosbuvir","References":[]},{"title2":"Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China","References":[]}]}]}